Clinical trial
A Protocol Based Treatment for Early and Severe Systemic Sclerosis With…
NCT00379431 · University Hospital, Ghent, Other · Completed
Key facts
| NCT number | NCT00379431 |
|---|---|
| Title | A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab |
| Official title | A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab |
| Lead sponsor | University Hospital, Ghent, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Early and Severe Systemic Sclerosis |
| Intervention type | Drug |
| Interventions | Administration of rituximab and methylprednisolone |
| Enrollment | 9 |
| Start date | Nov 27, 2006 |
| Primary completion | Feb 2, 2009 |
| Completion | Feb 2, 2009 |
| First posted | Sep 21, 2006 |
| Last update posted | Dec 20, 2022 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: